NCT04317677

Brief Summary

Sleep changes rapidly during the first year of life. Brain maturation is accompanied by sleep consolidation in several episode during day and night (daytime naps and night sleep) and progressive organization during the 24h period (more wake during day et more sleep during night). In the first months of life, sleep episodes are frequently interrupted by wake, possibly induced by multiple external and internal stimuli. One of this stimulus could be bladder voiding that is particularly frequent in babies. Only one team worked on the link between sleep and bladder voiding and reported that bladder voiding was associated with cortical arousal during a daytime nap in a little group of babies. In this study, investigators propose to study the relationship between sleep and bladder voiding in a bigger group of infant and during daytime but also nighttime sleep.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 19, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 23, 2020

Completed
9 months until next milestone

Study Start

First participant enrolled

December 9, 2020

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 9, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 9, 2025

Completed
Last Updated

January 30, 2025

Status Verified

January 1, 2025

Enrollment Period

5 years

First QC Date

March 19, 2020

Last Update Submit

January 28, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Occurrence of arousals / awakenings in a timely relation with bladder voiding.

    The occurrence of arousals and awakenings will be determined form polysomnography signals including electroencephalogram (EEG), electrooculogram (EOG) and a electromyogram (EMG). Arousals and awakenings will be scored as defined by the international rules for visual scoring of EEG (AASM manual 2007). Investigators will calculate the percentage of bladder voiding episode leading to arousal / awakening events

    24 hours

Secondary Outcomes (4)

  • Sleep stage following bladder voiding events

    24 hours

  • EEG frequencies following bladder voiding episodes

    24 hours

  • Heart rate following bladder voiding episode

    24 hours

  • Activity record with actigraphy in babies

    24 hours

Study Arms (1)

Babies hospitalized in the pediatric sleep unit

OTHER
Other: Study of the effect of bladder voiding on sleep fragmentation during day and night sleep

Interventions

Vigilance state of babies will be continuously recorded during the first 24 hours of hospitalization by polysomnography and actigraphy. In parallel, bladder voiding episodes will be detected with an innovative device placed on babies diapers.

Babies hospitalized in the pediatric sleep unit

Eligibility Criteria

Age1 Month - 12 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Infants of both sex
  • Age ≥1 month and ≤ 12 months
  • Referred to the sleep unit for sleep trouble screening following ALTE (Apparent Life Threatening Event).
  • Patients should benefit from appropriate insurance system
  • Parents who have expressed a willingness to participate in the study, who have signed and dated the informed consent.

You may not qualify if:

  • Neurological, endocrinal or syndromic diseases :
  • Head and neck congenital malformations
  • Pierre Robin Syndrome
  • Trisomy
  • Achondroplasia
  • Prader Willy syndrome
  • Ondine syndrome
  • Cardiac diseases and malformations
  • Weight \<2.5 kg
  • Preterm babies (under 37 weeks of gestational age)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service épilepsie, sommeil et explorations neuropédiatriques, Hôpital Femme mère enfant - Groupement hospitalier Est - HCL

Bron, 69500, France

RECRUITING

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 19, 2020

First Posted

March 23, 2020

Study Start

December 9, 2020

Primary Completion

December 9, 2025

Study Completion

December 9, 2025

Last Updated

January 30, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations